Albert Benjamin (CIK 2086403) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-11). Recent activity: Sell HCAT (35,244 shares), Sell HCAT (321 shares), Sell HCAT (34,485 shares), Sell HCAT (336 shares), Buy HCAT (1,124 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 35,244 | $59,023 |
| 2026-09-03 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 321 | $547 |
| 2026-06-15 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 34,485 | $58,280 |
| 2026-06-03 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 336 | $460 |
| 2026-05-01 | Health Catalyst, Inc. (HCAT) | CEO | Buy | 1,124 | $0 |
| 2026-05-01 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 310 | $418 |
| 2026-03-13 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 70,455 | $130,342 |
| 2026-03-05 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 4,966 | $8,244 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | CEO | Buy | 930,000 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | CEO | Buy | 38,833 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | CEO | Sell | 13,304 | $23,282 |
| 2025-09-26 | Health Catalyst, Inc. (HCAT) | President and COO | Buy | 467,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11